Tao Huang

Title: Innovations of Tao Huang in Cyclic Peptide Research

Introduction

Tao Huang is a prominent inventor based in Hong Kong, CN. He has made significant contributions to the field of cyclic peptide research, particularly in the development of agonists for galanin receptors. His work is crucial for addressing various health disorders related to these receptors.

Latest Patents

Tao Huang holds a patent titled "Identification of cyclic peptide agonists of galanin receptor 2 and 3 guided by spexin solution structure." This patent focuses on the design and synthesis of cyclic peptide agonists targeting human galanin receptor 2 (GalR2) and galanin receptor 3 (GalR3). The agonists, including LH101, LH102, and LH101 (Ac), are potent spexin analogs with prolonged action. They hold promise for treating GalR2 and GalR3-related diseases, as well as spexin-deficient disorders such as obesity.

Career Highlights

Tao Huang is affiliated with Hong Kong Baptist University, where he conducts his research. His innovative work has led to advancements in understanding the therapeutic potential of cyclic peptides. His research is vital for developing new treatment options for various health conditions.

Collaborations

Tao Huang collaborates with notable colleagues, including Zhaoxiang Bian and Chengyuan Lin. Their combined expertise enhances the research efforts in cyclic peptide agonists and their applications.

Conclusion

Tao Huang's contributions to cyclic peptide research and his innovative patent highlight his role as a leading inventor in the field. His work has the potential to significantly impact the treatment of disorders related to galanin receptors.